Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is a non‑ionic iodinated contrast medium presented as a sterile solution for intravenous use. It enhances radiographic visibility of vascular structures and organs during diagnostic imaging procedures in adult and pediatric patients.

GNH USA supplies Optiray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide, with a focus on quality and regulatory compliance.

Optiray (ioversol) is employed as an iodinated contrast agent to improve visualization in X‑ray based diagnostic imaging.

- Computed Tomography (CT): provides enhanced contrast of soft tissues and vasculature. - Angiography: delineates arterial and venous structures during vascular studies. - Urography: highlights urinary tract anatomy for assessment of kidneys, ureters and bladder.

Ioversol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Warm sensation at the injection site. - Metallic taste in the mouth. - Nausea or mild vomiting. - Transient headache. - Mild itching or rash.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis). - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Cardiovascular collapse or hypotension. - Pulmonary edema. - Seizures (rare).

Use of Optiray requires careful patient assessment and monitoring.

- Assess renal function: evaluate serum creatinine before administration. - Screen for iodine allergy: avoid in patients with known hypersensitivity. - Ensure adequate hydration: maintain fluid intake before and after the procedure. - Use the lowest effective volume: tailor dose to the specific imaging requirement. - Monitor vital signs: observe for immediate reactions during and after injection. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Optiray may interact with other medications, influencing safety and efficacy.

Major Interactions (Avoid): - Nephrotoxic drugs (e.g., aminoglycosides): increase risk of renal injury. - Metformin: may precipitate lactic acidosis in patients with impaired renal function. - Iodine‑containing medications (e.g., amiodarone): can augment total iodine load.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals a contrast reaction. - Diuretics: affect fluid balance and may potentiate renal effects of contrast.